Chaddy, Scotts presentation in November 2023 had a slide headed " Pathway to market entry ( Gen 1 during FY25)".
Since then; the company has continued to tick milestones, received a strategic investment from Keysight technologies (MC $26b US), strengthened the Board, and confirmed that preparations are well advanced for a pre-submission meeting with the FDA.
Things can always go wrong however this is a careful, considered company with top notch management.
Chaddy, Scotts presentation in November 2023 had a slide headed...
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.10 |
Change
-0.050(2.33%) |
Mkt cap ! $179.3M | |||
| Open | High | Low | Value | Volume |
| $2.12 | $2.14 | $2.03 | $32.34K | 15.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $2.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.10 | 9406 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.08 |
Change
-0.050 ( 0.61 %) |
||||
| Open | High | Low | Volume | ||
| $2.11 | $2.13 | $2.03 | 6767 | ||
| Last updated 15.42pm 03/05/2024 ? | |||||
| EMV (ASX) Chart |